SMTL ID : 6j6m.1

Co-crystal structure of BTK kinase domain with Zanubrutinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.25 Å

Oligo State

monomer

Ligands

1 x BA0: (7S)-2-(4-phenoxyphenyl)-7-(1-propanoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide(Covalent)

BA0.1: 19 residues within 4Å: Chain A: L.18, T.20, V.26, A.38, K.40, M.59, I.82, T.84, E.85, Y.86, M.87, G.90, C.91, N.94, R.135, L.138, S.148, D.149, F.150 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.26, A:A.38, A:K.40, A:L.138 Hydrogen bonds: A:E.85, A:M.87, A:M.87, A:N.94 pi-Stacking: A:F.150

1 x IMD: IMIDAZOLE(Non-covalent)

IMD.2: 4 residues within 4Å: Chain A: S.259, L.262, D.263, D.266 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.263 Water bridges: A:S.259, A:D.266

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Guo, Y. et al., Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J.Med.Chem. (2019)

Release Date

2019-10-23

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence